Parrillo Performance receives FDA warning letter for cGMP violations

Bodybuilding supplement manufacturer Parrillo Performance has received a warning letter from the FDA for an 'inadequate response' to an FDA 483 for alleged cGMP violations.

URL: http://mobile.nutraingredients-usa.com/Industry/Parrillo-Performance-receives-FDA-warning-letter-for-cGMP-violations?utm_source=RSS_text_news&utm_medium=RSS%2Bfeed&utm_campaign=RSS%2BText%2BNews
Enclosure: http://mobile.nutraingredients-usa.com/var/plain_site/storage/images/publications/food-beverage-nutrition/nutraingredients-usa.com/industry/parrillo-performance-receives-fda-warning-letter-for-cgmp-violations/7249083-1-eng-GB/Parrillo-Performance-receives-FDA-warning-letter-for-cGMP-violations_rss.jpg